Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid
Lagier, G.; Vincens, M.; Castot, A.
Therapie 38(3): 303-318
1983
ISSN/ISBN: 0040-5957 PMID: 6612667 Document Number: 200651
Document emailed within 1 workday
Related Documents
Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688Herring, L. 2001: Drug errors could be so easy to avoid Nursing Times 97(6): 21
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
Kshirsagar, N.A.; Karande, S.C.; Potkar, C.N. 1993: Adverse drug reaction monitoring in India Journal of the Association of Physicians of India 41(6): 374-376
Deshpande, N.S. 1993: Adverse drug reaction monitoring of ciprofloxacin Indian Pediatrics 30(7): 942-943
Berkman, M. 1972: Treatment of heart failure in general medical practice. Principles to follow. Errors to avoid La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 48(48): 3179-3188
Jabłecka, A.; Korzeniowska, K. 2010: The safety of pharmacotherapy in the light of monitoring adverse drug reaction Przeglad Lekarski 67(10): 1091-1092
Palojoki, S.; Borycki, E.M.; Kushniruk, A.W.; Saranto, K. 2017: A Comparison of two Principal Systems for Monitoring of Technology-Induced Errors in Electronic Health Records Studies in Health Technology and Informatics 245: 1108-1112
Farber, M.S.; Garabedian-Ruffalo, S.M. 1990: Applying drug-use evaluation principles to investigational or unlabeled drug use American Journal of Hospital Pharmacy 47(3): 598-599
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Venulet, J.; Ciucci, A.; Berneker, G.C. 1980: Standardized assessment of drug-adverse reaction associations--rationale and experience International Journal of Clinical Pharmacology Therapy and Toxicology 18(9): 381-388
Jewitt, D.; McComish, M.; Jackson, G. 1976: Ambulatory monitoring in the controlled assessment of anti-arrhythmic drug therapy Postgraduate Medical Journal 52(Suppl 7): 67-72
Zoppi, M.; Török, M.; Stoller-Güleryüz, D.; Winzenried, P.; Marty, H.; Hess, T.; Stucki, P.; Bickel, M.H.; Stocker, F.; Hoigné, R. 1982: Drug side effects as the probable cause of death. Results of the Berne Comprehensive Hospital Drug Monitoring Program Schweizerische Medizinische Wochenschrift 112(49): 1808-1810
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Mihu, D.; Imre, S.; Vlase, L.; Achim, M.; Cuciureanu, M. 2008: New method for determination of dydrogesterone in human plasma for therapeutic drug monitoring in gynecological disorders Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 112(3): 837-842
Shen, L.; Zhai, Y.; Ma, S.-Y.; Lin, X.; Feng, Y.; Ruan, K.-F. 2013: Comparative study on mathematical set-based drug release kinetics method and Kalman filter method applied in evaluating drug release of multi-component traditional Chinese medicine preparations Zhongguo Zhong Yao Za Zhi 38(8): 1165-1171
Ciorciaro, C.; Hartmann, K.; Kuhn, M. 1998: Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center) Schweizerische Medizinische Wochenschrift 128(7): 254-258
Hensjö, L.O. 1995: A new classification introduced in Fass (Swedish Drug Index). a simple way for assessment of drug interactions Lakartidningen 92(38): 3479-3480
Legrand, E.; Volney, B.éa.; Meynard, J.-B.; Mercereau-Puijalon, O.; Esterre, P. 2008: In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005 Antimicrobial Agents and ChemoTherapy 52(1): 288-298
Weidle, P.J.; Malamba, S.; Mwebaze, R.; Sozi, C.; Rukundo, G.; Downing, R.; Hanson, D.; Ochola, D.; Mugyenyi, P.; Mermin, J.; Samb, B.; Lackritz, E. 2002: Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance Lancet 360(9326): 34-40